Inmed pharmaceuticals strengthens executive leadership team with appointment of ms. netta jagpal as chief financial officer

Vancouver, british columbia--(newsfile corp. - february 9, 2024) - inmed pharmaceuticals inc. (nasdaq: inm) ("inmed" or the "company"), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today announced the appointment of ms. netta jagpal, cpa, ca as chief financial officer and corporate secretary, effective february 20, 2024.
INM Ratings Summary
INM Quant Ranking